NIMH collaborative multisite multimodal treatment study of ADHD. Richters, J. Journal of the American Academy of Child and Adolescent Psychiatry 34 (1995):987-1000.
3-year followup of the NIMH MTA Study. Jensen, P. Journal of the American Academy of Child and Adolescent Psychiatry 46 (2007):989-1002.
MTA at 8 years. Molina, B. Journal of the American Academy of Child and Adolescent Psychiatry 48 (2009):484-500.
Selective serotonin reuptake inibitors in childhood depression. Whittington, C. The Lancet 363 (2004):1341-5.
Depressing research. Editorial, The Lancet 363 (2004):1335.
Efficacy and safety of antidepressants for children and adolescents. Jureidini, J. British Medical Journal 328 (2004):879-83.
Psychotic side effects of stimulants. Cherland, E. Canadian Journal of Psychiatry 44 (1999):811-3.
Prior stimulant treatment in adolescents with bipolar disorder. DelBello, M. Bipolar Disorders 3 (2001):53-57.
Attention-deficit hyperactivity disorder and juvenile mania. Biederman, J. Journal of the American Academy of Child and Adolescent Psychiatry 35 (1996):997-1008.
Pediatric-onset bipolar disorder.Faeeda, G. Harvard Review of Psychiatry 3 (1995):171-95.
Bipolar disorder at prospective follow-up of adults who had prepubertal major depressive disorder. Geller, B. American Journal of Psychiatry 158 (2001):125-7.
Antidepressant exposure in bipolar children. Cicero, D. Psychiatry 66 (2003):317-22.
Pediatric bipolar disorder. Faedda, G. Bipolar Disorders 6 (2004):305-13.
Treatment-emergent mania in pediatric bipolar disorder. Faedda, G. Journal of Affective Disorders 82 (2004):149-58.
Long-term implications of early onset in bipolar disorder. Perlis, R. Biological Psychiatry 55 (2002):875-81.
Course and outcome of bipolar spectrum disorder in children and adolescents_ A review of the existing literature. Birmaher, B. Development and Psychophathology 18 (2006):1023-35.
Twelve-month outcome of adolescents with bipolar disorder following first hospitalization for a manic or mixed episode. DelBello, M. American Journal of Psychiatry 164 (2007):582-90.
Psychosocial functioning among bipolar youth. Goldstein, T. Journal of Affective Disorders 114 (2009):174-83.
Two-year prospective follow-up of children with a prepubertal and early adolescent bipolar disorder phenotype. American Journal of Psychiatry 159 (2002):927-33.
One Year After Discharge. Schooler, N. American Journal of Psychiatry 123 (1967): 986-995.
Relapse in Chronic Schizophrenics Following Abrupt Withdrawal of Tranquilizing Medication. Prien, R. British Journal of Psychiatry 115 (1968): 679-86.
Discontinuation of Chemotherapy for Chronic Schizophrenics. Prien, R. Hospital and Community Psychiatry 22 (1971): 20-23.
Comparison of Two Five-Year Follow-up Studies. Bockoven, J. American Journal of Psychiatry 132 (1975): 796-801.
The Treatment of Acute Schizophrenia Without Drugs. Carpenter, W. American Journal of Psychiatry 134 (1977): 14-20.
Are There Schizophrenics for Whom Drugs May be Unnecessary or Contraindicated? Rappaport, M. International Pharmacopsychiatry 13 (1978):100-111.
A Non-Neuroleptic Treatment for Schizophrenia. Mathews, S. Schizophrenia Bulletin 5 (1979), 322-332.
Community Residential Treatment for Schizophrenia. Mosher, L. Hospital and Community Psychiatry 29 (1978), 715-723
The Treatment of Acute Psychosis Without Neuroleptics. Mosher, L. International Journal of Social Psychiatry 41 (1995), 157-173.
Treatment of Acute Psychosis Without Neuroleptics. Bola, J. The Journal of Nervous and Mental Disease 191 (2003):219-229.
Maintenance Antipsychotic Therapy. Cole, J. American Journal of Psychiatry 132 (1977): 32-6.
Dopaminergic Supersensitivity After Neuroleptics. Muller, P. Psychopharmacology 60 (1978):1-11.
Neuroleptic-Induced Supersensitivity Psychosis: Chouinard, G. American Journal of Psychiatry 135 (1978):1409-1410.
Neuroleptic-Induced Supersensitivity Psychosis: Chouinard, G. American Journal of Psychiatry 137 (1980):16-20.
Neuroleptic-inducedsupersensitivity psychosis, the “hump course,” and tardive dyskinesia. Chouinard, G. Journal of Clinical Psychopharmacology 2 (1982):143-4.
The International Pilot Study of Schizophrenia. Leff, J. Psychological Medicine 22 (1992):131-145.
Schizophrenia: Manifestations, Incidence and Course in Different Cultures. Jablensky, A. Psychological Medicine, supplement 20 (1992):1-95.
Course of depressive symptoms over followup. Shea, M. Archives of General Psychiatry 49 (1992):782-87.
Do antidepressant and antianxiety drugs increase chronicity in affective disorders? Fava, G. Psychotherapy and Psychosomatics 61 (1994):125-31.
Can long-term treatment with antidepressant drugs worsen the course of depression? Fava, G. Journal of Clinical Psychiatry 64 (2003):123-33.
Holding on, depression, sensitization by antidepressant drugs, and the prodigal experts. Fava, G. Psychotherapy and Psychosomatics 64 (1995):57-61.
Potential sensitising effects of antidepressant drugs on depression. Fava, G. CNS Drugs 12 (1999): 247-56.
Risks and implications of interrupting maintenance psychotropic drug therapy. Baldessarini, R. Psychotherapy and Psychosomatics 63 (1005):137-41.
Can long-term andtidepressant use by depressogenic. El-Mallakh, R. Journal of Clinical Psychiatry 60 (1999):263.
Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness. Judd, L. American Journal of Psychiatry 157 (2000):1501-4.
One-year clinical outcomes of depressed public sector outpatients. Rush, J. Biological Psychiatry 56 (2004):46-53.
The Star D Project Results. Warden, D. Current Psychiatry Reports 9 (2007):449-59.
Outcome of anxiety and depressive disorders in primary care. Ronalds, C. British Journal of Psychiary 171 (1997): 427-3.
Treatment of depression related to recurrence. Weel-Baumgarten, E. Journal of Clinical Pharmacy and Therapeutics 25 (2000):61-6.
The impact of antidepressant treatment on population health. Patten, S. Population Health Metrics 2 (2004):9-16.
The effects of detection and treatment on the outcome of major depressoin in primary care. Goldberg, D. British Journal of General Practice 48 (1998):1840-4.
Pattern of antidepressant use and duration of depresson-related absence from work. Dewa, S. British Journal of Psychiatry 183 (2003):507-13.
Characteristics and significance of untreated major depressive disorder. Coryell, W. American Journal of Psychiatry 152 (1995):1124-9.
The naturalistic course of major depression in the absence of somatic therapy. Posternak, M. Journal of Nervous and Mental Disease 194 (2006):324-9.
Physical activity, exercise, depression and anxiety disorders. Strohle, A. Journal of Neural Transmission 116 (2009):777-84.
Breggin, Peter (1999). Psychostimulants in the treatment of children diagnosed with ADHD: Risks and mechanism of action. International Journal of Risk & Safety in Medicine, 12, 3-35.
more info >>
Breggin, Peter (2003/04). Suicidality, violence and mania caused by selective serotonin reuptake inhibitors (SSRIs). International Journal of Risk & Safety in Medicine, 16, 31-49.
more info >>
Breggin, Peter (2004). "Recent U.S., Canadian and British Regulatory Agency Actions Concerning Antidepressant-Induced Harm o Self and Others: A Review and Analysis." International Journal of Risk and Safety in Medicine, 16, 247-259.
more info >>
Breggin, P. (2000). What Psychologists and Psychotherapists Need to Know About ADHD and Stimulants. Changes: An International Journal of Psychology and Psychotherapy, 18, 13-23.
Breggin, P. (2000). The NIMH Multimodal Study of Treatment for Attention-Deficit/Hyperactivity Disorder: A Critical Analysis. International Journal of Risk and Safety in Medicine, 13, 15-22. Originally published in Ethical Human Sciences and Services, 2, 63-72.
Breggin, P. (2000). Confirming the Hazards of Stimulant Drug Treatment. The International Journal of Risk and Safety In Medicine, 13,199-120. Originally published in Ethical Human Sciences and Services, 2, 203-204.
Breggin, P. (2000). The Psychiatric Drugging of Toddlers. Ethical Human Sciences and Services, 2, 83-86.
Breggin, P. (1999). NIH Consensus Report Highlights Controversy Surrounding ADHD Diagnosis and Stimulant Treatment. Ethical Human Sciences and Services, 1, 9-11.
Healy, D. & Le Noury J. (2007). Pediatric bipolar disorder: An object of study in the creation of an illness. International Journal of Risk & Safety in Medicine, 19, 209–221.
Henderson, T.A. & Hartman, K. (2004). Aggression, Mania and Hypomania Induction Associated With Atomoxetine (Strattera). Pediatrics,114(3), 895-896.
Joseph, J. (2000). Problems in psychiatric genetic research: A reply to Faraone and Biederman. Developmental Review, 20, 582-593.
Joseph, J. (2002). Twin studies in psychiatry and psychology: Science or pseudoscience? Psychiatric Quarterly, 73, 71-82.
Joseph, J. (2000). Not in their genes: A critical view of the genetics of attention-deficit hyperactivity disorder. Developmental Review, 20, 539-567.
Lambert, N. (2002). Stimulant Treatment as a Risk Factor for Nicotine Use and Substance Abuse. In Jensen, P . S. & Cooper, J . R. (Eds.)., Attention Deficit Hyperactivity Disorder: State of the Science; Best Practices, (pp 18-1 to 18-24) Kingston, NJ : Civic Research Institute.
Lehman, P. (2002). Treatment-induced Suicide: Suicidality as a potential effect of psychiatric drugs. Journal of Critical Psychology, Counseling and Therapy, 2 (1).
Leo, Jonathan & Cohen, David (2003). Broken Brains or Flawed Studies? A Critical Review of ADHD Neuroimaging Research. The Journal of Mind and Behavior, 24(1), 29-56.
more info >>
Leo, J. & Lacasse, J.R. (2007). The Media and the Chemical Imbalance Theory of Depression. Springer Science.
McKay M. (2007). Forced Drugging of Children in Foster Care: Turning Child Abuse Victims into Involuntary Psychiatric Patients. JOM, 22 (2).
Turner, E., Matthews, A., Linardatos, E., Tell, R., & Rosenthal, R. (2008). Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy. New England Journal of Medicine, 358 (3), 252-260.
Washington, W., Human R., Zimbardo, P., & Antonuccio, D. (2007). Corporate Funding and Conflicts of Interest: A Primer for Psychologists. American Psychologist (December 2007).
Whitaker, R. (2004). The Case Against Antipsychotic Drugs: A 50-Year Record of Doing More Harm Than Good. Medical Hypotheses, 62, 5-13.
Whitaker, R. (2005). Anatomy of an Epidemic: Psychiatric Drugs and the Astonishing Rise of Mental Illness in America. Ethical Human Psychology and Psychiatry, 7, 23-35.
2018 Conference - STRONGER TOGETHER
May 4, 2018 - May 5, 2018
Embassy Suites - Destiny